We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.

christian angermayer
co-founder & chairman of the board
shannon klinger
member of the board of directors
teresa deluca md, mba
member of the board of directors
aaron weaver cfa
member of the board of directors
gregory weaver mba
member of the board of directors
aksana labokha phd
chief executive officer
caleb morgret cfa
chief financial officer
karim allam mba, llm, ccp
chief legal & people officer
matthias steger phd mba
patrick schnider phd
vp medicinal chemistry - rejuveron telomere therapeutics
prof. manuel serrano phd
co-founder & scientific advisor - rejuveron senescence therapeutics
timothy cash phd
co-founder & chief scientific officer - rejuveron senescence therapeutics
tristan heintz phd
chief scientific officer - rejuveron vascular therapeutics
chien chi hsiao phd
head of medicinal chemistry - rejuveron telomere therapeutics
marianna feretzaki phd
chief executive officer a.i. - rejuveron telomere therapeutics
wareed ahmed phd
senior scientist - rejuveron telomere therapeutics
pierre-antoine mudry bba ms
head, corporate finance and investor relations
kara chatelin
head of finance
daniele lionetti msc
finance associate
naffi wade
director compliance & strategic projects
lisa caflisch
lab operations manager & bso
csaba budai
it operations manager
malaika schroeder ma
director marketing & communications
dovaine picazo
executive assistant
prof. hideyuki okano md phd
member of the scientific advisory board
prof. lee rubin phd
co-founder - rejuveron vascular therapeutics